Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2005

FR Doc 05-3028 [Federal Register: February 17, 2005 (Volume 70, Number 32)] [Notices] [Page 8112] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17fe05-59]


Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated October 18, 2004, and published in the Federal Register on October 25, 2004, (69 FR 62295), Cody Laboratories, Inc., 301 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic class of controlled substances listed in Schedule II:

Drug Schedule
Amphetamine (1100) II 
Methamphetamine (1105) II 
Amobarbital (2125) II 
Pentobarbital (2270) II 
Secobarbital (2315) II 
Cocaine (9041) II 
Oxycodone (9143) II 
Dihydromorphine (9145) II 
Hydromorphone (9150) II 
Diphenoxylate (9170) II 
Meperidine (9230) II 
Oxymorphone (9652) II 
Sufentanil (9740) II 
Fentanyl (9801) II 

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. 

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cody Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 11, 2005. 

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. 

[FR Doc. 05-3028 Filed 2-16-05; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility